New Upright Radiotherapy System Enters Manufacturing
The technology, based on research from Stanford University, will be integrated into Leo Cancer Care platforms with the first installation at Mayo Clinic.
The technology, based on research from Stanford University, will be integrated into Leo Cancer Care platforms with the first installation at Mayo Clinic.
New pathways allow health systems to update legacy imaging equipment with artificial intelligence and workflow tools while preserving existing infrastructure.
New guidance across eight domains developed by Coalition for Health AI members provides a step-by-step roadmap for transparent, trusted AI governance.
The technology, based on research from Stanford University, will be integrated into Leo Cancer Care platforms with the first installation at Mayo Clinic.
The new mobile experience connects technicians, clinical staff, and hospital leaders on a single platform to help accelerate issue resolution and improve visibility across medical equipment service.
New technologies showcased at SNMMI 2026 aim to support precision care and streamline workflows as adoption of targeted therapies grows.
The low-profile overlay is designed for use during extended surgeries to reduce the risk of hospital-acquired pressure injuries.
The appointment aims to accelerate the development of AI-powered healthcare supply chain solutions and data-driven platform capabilities.
Test equipment leaders from BC Group, Rigel Medical, Pronk Technologies, and Fluke Biomedical discuss changing customer expectations, the rise of automation, and where diagnostic tools are headed next.Â
The Kosmos platform update includes FDA-cleared presets for obstetrics, gynecology and billable vascular workflows designed for point-of-care use.
The new EB-710US device aims to reduce infection risks and streamline procedure preparation by eliminating the use of disposable balloons.
The device features technology that automatically adjusts oxygen delivery to a patient’s breathing rate, a feature recently evaluated in a university bench study.
New data from a 15,000-patient registry and a comparative effectiveness study show AI-based plaque analysis may outperform conventional cardiac testing in identifying high-risk patients and guiding preventive treatment.
The system automates proximity tracking across patients, staff, and assets to support faster, more informed infection prevention decisions.